4//SEC Filing
Young Alethia 4
Accession 0001918147-25-000004
CIK 0001761612other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:45 PM ET
Size
7.6 KB
Accession
0001918147-25-000004
Insider Transaction Report
Form 4
Young Alethia
Chief Financial Officer
Transactions
- Sale
Ordinary Shares
2025-10-02$8.61/sh−265$2,280→ 44,704 total - Sale
Ordinary Shares
2025-10-02$8.40/sh−217$1,823→ 44,969 total
Footnotes (3)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.37 to $8.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on April 3, 2025.
Documents
Issuer
BICYCLE THERAPEUTICS PLC
CIK 0001761612
Entity typeother
Related Parties
1- filerCIK 0001918147
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:45 PM ET
- Size
- 7.6 KB